Defence Therapeutics Announces Warrant Terms Amendment

AI Briefing

• – Warrants to be exercised at $0.10 per common share for 5 years.
• – Amendment increases total warrant share purchase price and number of warrants.
• – Amendment is subject to TSXV approval and regulatory review.